STAT

OCTOBER 19, 2023

Mark Zuckerberg and Priscilla Chan sit atop a fortune that is currently valued at $113 billion, and they’ve promised to give almost all of it away. Their philanthropic funding group, the Chan Zuckerberg Initiative, is committed to investing in an array of fields, including science, education, housing insecurity, and expanding access to startup capital to entrepreneurs of color.

Compounding 335

Compounding 335

PharmaVoice

OCTOBER 19, 2023

The actor of “Heroes” and “Star Wars: The Force Awakens” fame is starring in another role as a patient advocate for people with epilepsy.

347

347

STAT

OCTOBER 19, 2023

When Michael J. Fox was diagnosed with Parkinson’s disease at age 29, his clearest symptom was a small one — his pinky finger was twitching. But even by that stage, 70% to 80% of a patient’s dopamine-producing cells are already gone, Fox said. “What happens in that time, that shadowy place?” Fox said, referring to the period before his pinky finger first started twitching.

333

333

PharmaVoice

OCTOBER 19, 2023

Industry leaders adopting cutting-edge technologies and strategies to change the paradigm of clinical research.

130

130

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

OCTOBER 19, 2023

RNA medicines startup Laronde is merging with another startup in the wake of a scientific misconduct issue that affected its leading drug candidates. Laronde was founded by biotech creation firm Flagship Pioneering in 2017 to develop a new type of genetic medicine called endless RNA. It quickly attracted more than $440 million from investors including Fidelity, Blackrock, and the Canadian Pension Plan.

321

321

The Pharmacist

OCTOBER 19, 2023

Regulating against medicine misinformation is one of several recommendations to governments made by the International Pharmaceutical Federation (FIP) in a newly published statement of policy. The new policy statement, replacing one published in 2017, also takes into account the increasing use of digital information sources, including artificial intelligence, and puts a stronger emphasis on the […] The post FIP urges governments to address medicine misinformation appeared first on The Pharm

105

105

The Pharmacist

OCTOBER 19, 2023

The Department of Health and Social Care has refuted a claim that it has failed to meet a commitment to review the funding model for community pharmacy. The DHSC has today published its response to a report by the Health and Social Care Committee (HSCC) that found the government’s progress on its commitments to support […] The post DHSC rejects claim it failed on promise to review community pharmacy funding appeared first on The Pharmacist.

Community Pharmacies 101

Community Pharmacies 101

STAT

OCTOBER 19, 2023

Two years after a big scientific swing nearly pushed Biogen to the brink, CEO Christopher Viehbacher is embarking on a corporate rethink, one that balances Biogen’s characteristic risky bets with a frank commitment to pragmatism. Speaking at the STAT Summit in Boston on Thursday, Viehbacher said his Biogen predecessors fell off track through a few unsound investments and an all-or-nothing bet on Aduhelm, the Alzheimer’s disease treatment that became a pharmaceutical cautionary tale

295

295

BioPharma Dive

OCTOBER 19, 2023

The base editing specialist will prioritize medicines for sickle cell and alpha-1 antitrypsin deficiency, while trimming its plans for other programs in cancer and hepatitis B.

109

109

STAT

OCTOBER 19, 2023

WASHINGTON — Richard Nixon was the president when the Food and Drug Administration issued its first warnings about brominated vegetable oil, based on reports it could harm a slew of vital organs, from the liver to the heart. But the agency still hasn’t actually banned the ingredient — it only sent a proposed ban to the White House in August.

Grocery Stores 282

Grocery Stores 282

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Express Pharma

OCTOBER 19, 2023

Aragen has commissioned its new formulations manufacturing facility in Hyderabad, India. This facility, set up at an investment of $3 million, is located at the Mallapur Campus in Hyderabad and spans over 12,000 square feet area. The company informed that it is equipped to support the clinical manufacturing of a wide range of dosage forms, including oral solids, liquids, topicals, and films.

Dosage 102

Dosage Drug Development 102

STAT

OCTOBER 19, 2023

The story of GSK is one of reinvention, CEO Emma Walmsley said at the STAT Summit in Boston on Thursday. Having shed its consumer division, the British drug giant is writing a new chapter as a pure-play biopharma company dedicated to the prevention, as well as treatment, of disease. GSK’s recent launch of a new RSV vaccine for adults is emblematic of this move, adding to a portfolio that includes other vaccines, such as the very successful Shingrix for shingles, as well as drugs for HIV,

Vaccines 280

Vaccines 280

Pharma Times

OCTOBER 19, 2023

The considerations will help to develop new or existing guidance on AI - News - PharmaTimes

130

130

STAT

OCTOBER 19, 2023

MADRID — Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy treatments.   The deal includes a $4 billion upfront payment and an additional $1.5 billion over the next two years. Up to $16.5 billion more is on the table depending on the success of the drugs in development.

Chemotherapy 271

Chemotherapy Drug Development 271

European Pharmaceutical Review

OCTOBER 19, 2023

According to the European Medicines Agency (EMA), pre-filled pens falsely labelled as the type 2 diabetes medicine Ozempic ( semaglutide , 1mg, solution for injection) have been identified at wholesalers in the EU and the UK. The pens, with labels in German, originated from wholesalers in Austria and Germany. There are differences in the appearance between the falsified pen and the original pen.

Diabetes 96

Diabetes Labelling 96

STAT

OCTOBER 19, 2023

WASHINGTON — The House Energy & Commerce health subcommittee kicked off its first hearing in four years on whether to reform the way Medicare pays doctors. But they didn’t discuss how to pay for those changes. Lawmakers brought up 23 different bills on the topic, many of which are drafts that haven’t been introduced. A few bills addressed expiring payment initiatives.

267

267

Pharma Times

OCTOBER 19, 2023

HIV affects approximately 39 million people worldwide and can lead to AIDS - News - PharmaTimes

122

122

STAT

OCTOBER 19, 2023

What if CRISPR isn’t all that commercial? How does the NurOwn story end? And how do you pronounce “Bayer”? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Live from Boston at the 2023 STAT Summit, we discuss the latest news in the life sciences, including a milestone in genome editing, a twist in the search for ALS treatments, and the polarizing process of saying words in biotech.

244

244

Express Pharma

OCTOBER 19, 2023

Mestastop Solutions, a biotechnology startup, has raised Rs 4.5 crores or $500k in a Pre Series A round led by 92 angels and Malpani Ventures. In 2021 the company had secured a seed funding of Rs 2 crores led by IIM Ahmedabad’s CIIE with participation from IKP and angel investors. Founded by Arnab Roy Chowdhury and Debabani Roy Chowdhury, Mestastop is creating a cancer metastasis focussed platform, which uses wet lab biology and predictive analytics to identify and distinguish unique properties

90

90

STAT

OCTOBER 19, 2023

Beam Therapeutics said Thursday morning it would lay off 20% of its staff — or around 100 employees — and pause or reevaluate certain programs as it looks to cut costs. It’s a notable setback for a gene-editing company that quickly raised over $1 billion in the few years after its co-founder, David Liu, described a new form of CRISPR, called base editing, that allowed researchers to change individual letters of DNA.

243

243

Outsourcing Pharma

OCTOBER 19, 2023

A collaboration has been formed between the US pharmacy chain Walgreens and the Cardiovascular Research Foundation (CRF) to measure how prevalent valvular heart disease (VHD) is among older Americans.

86

86

STAT

OCTOBER 19, 2023

New technology has a history of overwhelming existing systems that try to manage it, and that’s proving to be the case with genetic testing and health care. It’s been only 20 years since the completion of the Human Genome Project opened the door for genetic testing and its promise for more lifesaving screenings and precise, personalized medicine.

237

237

Pharmaceutical Technology

OCTOBER 19, 2023

Adcetris/AVD is already approved as a first-line treatment for patients with CD30+ Stage IV Hodgkin lymphoma.

Labelling 105

Labelling Drug Development 105

STAT

OCTOBER 19, 2023

Europe’s major cancer research conference kicks off in Madrid on Friday, with headline — and potentially practice-changing — readouts from trials in lung, prostate, and other types of cancer. STAT will be reporting from the annual meeting of the European Society for Medical Oncology through Monday. Here are just a few of the presentations we’ll be keeping an eye on at this year’s conference.

222

222

Outsourcing Pharma

OCTOBER 19, 2023

Physics-powered GenAI Biotech, Gero, announced yesterday (October 18) that it had closed a $6 million series A extension round with funding from Melnicheck Investments and other investors.

78

78

STAT

OCTOBER 19, 2023

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hello, everyone. Damian here with the highlights from the STAT Summit, a question on CRISPR, and career advice from a biotech elder statesman.

Drug Development 216

Drug Development 216

Outsourcing Pharma

OCTOBER 19, 2023

Clerkenwell Health is partnering with Transcend Therapeutics to trial the use of methylone in patients with severe post-traumatic stress disorder (PTSD).

84

84

STAT

OCTOBER 19, 2023

Renee Salas, an emergency medicine physician at Massachusetts General Hospital, blames climate change for the sinking feeling she had so often in the ER. “I often feel like I’m in the emergency department pulling patients out of a river, only to see many more behind,” she told STAT’s Sarah Owermohle on Thursday at the STAT Summit in Boston.

Hospitals 204

Hospitals 204

World Pharma News

OCTOBER 19, 2023

An American born in 2019 will spend a larger share of their lifetime taking prescription drugs than being married or receiving an education, according to new research by Jessica Ho, associate professor of sociology and demography at Penn State. She found that American males will spend approximately 48% of their lives taking prescription drugs. The number jumped to 60% for females.

81

81

PharmaTech

OCTOBER 19, 2023

In this episode of the Drug Solutions Podcast, industry experts discuss the challenges and advantages of the digitalization trend in the biopharma industry, with particular emphasis on the impacts to biomanufacturing.

75

75

pharmaphorum

OCTOBER 19, 2023

Pfizer sets Paxlovid price at nearly $1,400 per course Phil.

112

112

Outsourcing Pharma

OCTOBER 19, 2023

The Gen AI revolution promises to redefine various industries, with the life sciences sector at the forefront of this transformation. OSP had the chance to speak to Tarun Mathur, CEO at Indegene, who was keen to allay many of the fears those in the industry may have.

64

64

pharmaphorum

OCTOBER 19, 2023

One Health: The interconnection of animal and human health Mike.

103

103

Drug Patent Watch

OCTOBER 19, 2023

Annual Drug Patent Expirations for IGALMI Igalmi is a drug marketed by Bioxcel and is included in one NDA. It is available from one supplier. There are four patents protecting… The post New patent for Bioxcel drug IGALMI appeared first on DrugPatentWatch - Make Better Decisions.

59

59

pharmaphorum

OCTOBER 19, 2023

Lilly makes another ADC play, buying Mablink Phil.

108

108